OS THERAPIES INC

Profile

Company Names

OS THERAPIES INC

Addresses

115 PULLMAN CROSSING ROAD, SUITE 103, GRASONVILLE, MD 21638

115 PULLMAN CROSSING ROAD, SUITE #103, GRASONVILLE, MD 21638

15825 SHADY GROVE ROAD, SUITE 135, ROCKVILLE, MD 20850

104 TECH PARK DRIVE, UNIT 2404, CAMBRIDGE, MD 21613

3412 NORTH ABINGDON STREET, ARLINGTON, VA 22207

Phone Numbers

410-297-7793
(410) 297-7793
410.304.2092
703-541-9811

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$24,655,252.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2026-03-04 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
8
2026-01-14 
$3,498,650.00 
$7,531,884.00 
$4,033,234.00 
Equity 
7
2025-09-02 
$3,777,808.00 
$3,777,808.00 
$0.00 
Equity 
6
2025-06-23 
$4,216,794.00 
$4,216,794.00 
$0.00 
Equity 
5
2024-12-31 
$7,103,000.00 
$10,000,000.00 
$2,897,000.00 
Equity 
4
2023-12-08 
$700,000.00 
$2,000,000.00 
$1,300,000.00 
 
3
2022-11-16 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
2
2021-07-15 
$1,000,000.00 
$5,000,000.00 
$4,000,000.00 
Debt 
1
2018-07-25 
$359,000.00 
$500,000.00 
$141,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
ACEVEDO 
EXECUTIVE OFFICER
CHRISTOPHER 
P. 
ACEVEDO 
EXECUTIVE OFFICER
JOACIM 
 
BORG 
DIRECTOR
JOHN 
 
CICCIO 
DIRECTOR
GERALD 
 
COMMISSIONG 
EXECUTIVE OFFICER
KARIM 
 
GALZAHR 
DIRECTOR
COLIN 
 
GODDARD 
DIRECTOR
OLIVIER 
 
JARRY 
DIRECTOR
OLIVIER 
R. 
JARRY 
DIRECTOR
AVRIL 
 
MCKEAN DIESER 
DIRECTOR
ROBERT 
 
PETIT 
EXECUTIVE OFFICER
ROBERT 
G. 
PETIT 
EXECUTIVE OFFICER
PAUL 
 
ROMNESS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PAUL 
A. 
ROMNESS 
EXECUTIVE OFFICER, DIRECTOR
THEODORE 
 
SEARCH 
DIRECTOR
THEODORE 
F. 
SEARCH 
DIRECTOR
JUTTA 
 
WANNER 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2026-03-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-01-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-09-02 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-23 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-12-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-12-08 
D
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-11-16 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2021-07-15 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2018-07-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CEROS FINANCIAL SERVICES, INC.
ARCADIA SECURITIES
BROOKLINE CAPITAL MARKETS
NONE
NONE
CEROS FINANCIAL SERVICES, INC.
NONE
NONE
NOBLE CAPITAL MARKETS, INC.